[ad_1]
WASHINGTON :
There is close cooperation between India and the United States on the exchange of information related to the development of vaccines to counter the COVID-19 pandemic, Ambassador Taranjit Singh Sandhu said on Saturday, adding that Indian and American companies are currently working together . in at least three vaccines.
Sandhu said the crown crisis has presented India with an unexpected opportunity to expand its manufacturing base and play a “significant” role in the recovery process of global supply chains. “I think American investors are smart, American companies are smart, and they are moving to connect, and already at the company level, it is being done,” he said.
The ambassador told ANI that the Indian Council for Medical Research (ICMR) and the Center for Disease Control and Prevention (CDC), as well as the National Institutes of Health (NIH), have been collaborating with each other for several years. . “In fact, about two or three years ago, together we developed a vaccine for another virus. It is called a rotavirus. It has helped, not only in India but also in the United States and many other countries,” he said.
“So this time too, there is close cooperation on the exchange of information related to the pandemic. Also, as I said, there are at least three vaccines, on which Indian companies and American companies are working together,” said the ambassador. . additional.
On top of that, the ambassador said India is an important part of the supply chain, and this particular crisis has certainly proved to the United States, if not the entire world, that India is a reliable partner. “Regardless of the assistance that they (the United States) required in terms of the supply chain, India has been able to deliver on that, and this has been recognized by the highest level in the United States government,” he said.
A shipment of hydroxychloroquine from India arrived in the United States last month, days after New Delhi lifted the ban on exporting the antimalarial drug, seen as a possible cure for COVID-19, to the United States and other countries. for humanitarian reasons. . The export of the drug was authorized by the Indian authorities at the request of the President of the United States, Donald Trump.
Meanwhile, the ambassador said the crown crisis has presented India with an unexpected opportunity to expand its manufacturing base and play a “significant” role in the recovery process of global supply chains.
“Economically, I mean, challenges also come opportunities. As I mentioned, this time is a particular challenge for the United States and India. We have held together. Especially economically, it has definitely provided an opportunity for both Indian companies like the US for developing a stronger bond. Now, regardless of China, India has been an attractive destination. And certainly, in the post-underground time, India will be an important part of the recovery process, “said the ambassador. ANI.
“And I think that American investors are smart, American companies are smart, and they are moving to connect and already at the company level, it is already being done. The Government of India has also taken the initiative, and is laying the carpet ” Previously we have also had investments in FDI. I am sure there will be a stronger link between our two countries, “he added.
.
[ad_2]
